BetterLife Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is February - January.

Millions USD. Fiscal year is Feb - Jan.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 25, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022	Jan '21 Jan 31, 2021
Market Capitalization	7	11	6	10	14	55
Market Cap Growth	-36.63%	77.29%	-35.21%	-26.56%	-75.00%	197.60%
Enterprise Value	10	15	8	13	12	57
Last Close Price	0.05	0.09	0.06	0.11	0.16	1.06
PB Ratio	-1.57	-2.26	-1.13	-1.77	-4.47	-15.11
Debt / Equity Ratio	-0.12	-0.18	-0.07	-0.02	-0.08	-0.11
Net Debt / Equity Ratio	-0.12	-0.18	-0.07	-0.02	-0.04	-0.07
Net Debt / EBITDA Ratio	-	-	-0.16	-0.02	-0.01	-0.04
Net Debt / FCF Ratio	-3.43	-0.65	-0.21	-0.12	-0.01	-0.05
Quick Ratio	0.00	0.00	0.01	0.00	0.12	0.12
Current Ratio	0.05	0.03	0.04	0.01	0.28	0.23
Return on Assets (ROA)	-445.30%	-1074.42%	-1004.42%	-936.16%	-493.00%	-103.39%
Return on Capital Employed (ROCE)	33.00%	64.60%	45.70%	130.90%	334.40%	177.50%
Earnings Yield	-19.11%	-21.15%	-33.29%	-67.53%	-70.08%	-52.15%
FCF Yield	-	-12.15%	-28.49%	-11.26%	-64.57%	-10.29%
Buyback Yield / Dilution	-16.79%	-13.34%	-26.25%	-14.70%	-179.24%	-79.75%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.